Continuous Interstitial Glucose Monitoring througha Long-Term Subcutaneous Implantable Sensorduring Pregnancy in Type 1 Diabetes: A Two-Patient Case Report
The subcutaneous sensor replacement was carried out at the beginning and end of the 2nd trimester, respectively, without any complications, allowing optimal monitoring and adjustment of insulin dose and achieving optimal glucose targets throughout the pregnancy until delivery.
Authors
- Federica Mazzoleni (ORCID: https://orcid.org/0009-0001-9895-8916)
- Antea Ciafardini (ORCID: https://orcid.org/0009-0006-3832-8169)
- Nazarena Betella (ORCID: https://orcid.org/0000-0002-1791-789X)
- Antonio Bossi (ORCID: https://orcid.org/0000-0001-8900-1787)
- Veronica Resi (ORCID: https://orcid.org/0000-0002-8443-7773)
- Walter Vena (ORCID: https://orcid.org/0000-0002-9288-6261)
- Emanuela Orsi
- Alessia Gaglio
Institutions
- Humanitas University (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Humanitas Gavazzeni (IT)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2025-08-18
- DOI
- https://doi.org/10.2174/0118715303393466250807050121
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00